Please login to view this media
- Talk
- 23/09/2021
- UK
Biological Injectables for OA; What, When and Why? Introduction and Setting the Scene
Description
In this session, Fares Haddad introduces a discussion on the challenges and opportunities within the field of regenerative medicine, specifically focusing on osteoarthritis treatment. He begins by acknowledging the excitement surrounding the potential for advanced therapeutic options that could halt the progression of osteoarthritis, especially in light of current healthcare challenges. Haddad emphasizes the importance of bridging the gap between scientific advancements and clinical practice, highlighting that although regeneration is a promising area, clinical use may be outpacing scientific validation. He discusses various therapeutic approaches, stresses the need for oversight and clarity about treatment options, and points out the significant market for regenerative therapies driven by patient demand.
As the talk progresses, Haddad outlines the complexities surrounding the treatment of osteoarthritis, noting the diversity of biological targets and the varied stages of the disease. He underscores that the effectiveness of therapies will depend on aligning biological activity with specific clinical goals and calls for the orthopedic profession to collaborate and develop comprehensive solutions rather than relying on a single treatment approach.
Haddad concludes by expressing optimism for the future, emphasizing the need for a thorough appraisal of current practices and advocating for well-defined outcome measures in clinical trials. He sets the stage for the next speaker, Iain Murray, who will focus on establishing research guidelines in regenerative therapies.